CAMBRIDGE, Mass., Jan. 9 — Archemix Corp. today announced that it has signed an agreement with Pfizer focused on the discovery of first-in-class aptamers for the development and commercialization as therapeutics.As part of the collaboration, Archemix will use its proprietary …